Clinical Trial Update: Treatment of LSCD With DM [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating DM for treatment of limbal stem cell deficiency in congenital aniridia conducted by the University of Minnesota has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Aniridia
• Limbal Stem Cell Deficiency

Snippet

Sponsor: University of Minnesota | Conditions: Limbal Stem-cell Deficiency, Congenital Aniridia | Phase 1 | Status: COMPLETED